NCT06863402 2026-03-24Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma SubtypeRoswell Park Cancer InstitutePhase 2 Recruiting32 enrolled
NCT06572618 2026-03-13Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell LymphomaCity of Hope Medical CenterPhase 2 Recruiting27 enrolled